GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » EBITDA Margin %

ViaDerma (ViaDerma) EBITDA Margin % : 40.31% (As of Jun. 2012)


View and export this data going back to 2008. Start your Free Trial

What is ViaDerma EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. ViaDerma's EBITDA for the three months ended in Jun. 2012 was $2.35 Mil. ViaDerma's Revenue for the three months ended in Jun. 2012 was $5.82 Mil. Therefore, ViaDerma's EBITDA margin for the quarter that ended in Jun. 2012 was 40.31%.


ViaDerma EBITDA Margin % Historical Data

The historical data trend for ViaDerma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma EBITDA Margin % Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
EBITDA Margin %
-777.78 36.75 27.90 34.76 36.07

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.48 31.76 41.26 40.74 40.31

Competitive Comparison of ViaDerma's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ViaDerma's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ViaDerma's EBITDA Margin % falls into.



ViaDerma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ViaDerma's EBITDA Margin % for the fiscal year that ended in Dec. 2011 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2011 )/Revenue (A: Dec. 2011 )
=6.857/19.008
=36.07 %

ViaDerma's EBITDA Margin % for the quarter that ended in Jun. 2012 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2012 )/Revenue (Q: Jun. 2012 )
=2.345/5.817
=40.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ViaDerma  (OTCPK:VDRM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


ViaDerma EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of ViaDerma's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ViaDerma (ViaDerma) Business Description

Traded in Other Exchanges
N/A
Address
4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.